-
2021/02/12
- Financial Results and Presentation Materials for the 2nd Quarter of the Fiscal Year ending June 2021
-
2021/02/10
- Please Be Noted About Spoofed Email Pretending Asahi Intecc
-
2020/12/11
- (Correction) Notice Regarding Partial Correction of the “Oncolys and ASAHI INTECC CO., LTD. Announces Conclusion of Capital and Business Alliance”
-
2020/12/10
- Oncolys and ASAHI INTECC CO. LTD. Announces Conclusion of Capital and Business Alliance
-
2020/12/02
- Notice Regarding Network Issues due to Unauthorized Access (3)
-
2021/02/12
- Financial Results and Presentation Materials for the 2nd Quarter of the Fiscal Year ending June 2021
-
2021/02/10
- Please Be Noted About Spoofed Email Pretending Asahi Intecc
-
2020/12/11
- (Correction) Notice Regarding Partial Correction of the “Oncolys and ASAHI INTECC CO., LTD. Announces Conclusion of Capital and Business Alliance”
-
2020/12/10
- Oncolys and ASAHI INTECC CO. LTD. Announces Conclusion of Capital and Business Alliance
-
2020/12/02
- Notice Regarding Network Issues due to Unauthorized Access (3)
-
2020/07/16
- Notice Regarding Registration Completion (Incorporation of the Company) of Overseas Sales Sub-Subsidiary “ASAHI INTECC Deutschland GmbH”
-
2020/04/10
- Notice Regarding Establishment of Overseas Sales Sub-subsidiary ASAHI INTECC Deutschland GmbH
-
2020/04/10
- Asahi Intecc to Begin Direct Sales in German Market
-
2020/03/13
- Asahi Intecc to Begin Direct Sales of Its Products for Interventional Cardiology in Korea
-
2020/02/14
- Notice Regarding Establishment of Overseas Sales Subsidiary Asahi Intecc EUROPE B.V.
